Please login to the form below

Not currently logged in


This page shows the latest BioNTech news and features for those working in and with pharma, biotech and healthcare.

Researchers call on Pfizer to delay COVID-19 vaccine application

Researchers call on Pfizer to delay COVID-19 vaccine application

The letter comes after reports last week that Pfizer and its partner BioNTech were expecting conclusive results from a study of their mRNA-based shot in October, raising concerns that the ... The researchers urged Pfizer and BioNTech to delay filing the

Latest news

More from news
Approximately 12 fully matching, plus 25 partially matching documents found.

Latest Intelligence

  • Working together against COVID-19 Working together against COVID-19

    Beyond the connection between HCPs and pharma or NGOs, it is encouraging to see collaborations such as Clover and GSK evaluating a vaccine candidate and Pfizer and Biontech doing the same.

  • COVID-19: the race to find a vaccine COVID-19: the race to find a vaccine

    BioNTech, CureVac and Translate Bio are also working on mRNA vaccines, while Pfizer and Sanofi are involved in those programmes through partnerships with BioNTech and Translate Bio, respectively.

  • Cancer immunotherapy: What's on the horizon? Cancer immunotherapy: What's on the horizon?

    Candidates from Neon Therapeutics, Aduro and BioNTech have passed early-stage testing and are now being studied along with checkpoint inhibitors to see if they can deliver a double-whammy to

  • Deal Watch September 2016 Deal Watch September 2016

    At a lower disclosed headline value of $310m BioNTech licensed its mRNA-based cancer vaccines platform to Genentech. ... The full value cannot be determined as BioNTech received the $310m in upfront and near-term milestone payments, no other financial

  • Deal Watch November 2015 Deal Watch November 2015

    Sanofi will gain access to BioNTech's mRNA formulation technology to generate new cancer immunotherapies. ... Option to US co-promote. 1, 700. BioNTech. Sanofi. Collaboration, licence - multi yr.

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest appointments

  • New hires at bluebird bio, BioNTech and Provention Bio New hires at bluebird bio, BioNTech and Provention Bio

    BioNTech. German biotech BioNTech has appointed Ryan Richardson(pictured below, right) as chief strategy officer and managing director. ... In his new role, he will support and contribute to the creation and implementation of BioNTech’s long-term growth

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company
Attigo (part of the Mednet Group)

Inclusion drives innovation. Attigo, a social enterprise, helps pharma and the socially conscious business shape the future by engaging with...

Latest intelligence

Switzerland: a life sciences hub
Switzerland has a rich diversity of pharma and biotech companies that sustain activity and help maintain its reputation as a highly innovative country...
Responding to dynamic shifts in value communications
OPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means for pharmaceutical companies....
Doing what we can and having fun doing it: our fundraising month
Charities are facing a number of challenges just to stay afloat amidst the current COVID-19 pandemic. Fundraisers are being cancelled and public donations are not as abundant as they have...